|Dr. Jimmy Bomanji|
"Our mission is clear; to apply the wonderful biological research performed on the UCL campus directly to overcome the diseases inflicting our patients here at University College Hospital and beyond. Being one of the most active clinical departments in Europe and committed to providing the highest imaging and therapeutic services to our patients.
The 21st century has placed imaging in a unique position amongst research and clinical tools. It is central to accurately diagnosing our patients as well as guiding our clinicians to the best treatment for each patient." - Prof. Ashley Groves
|"My vision is to provide deliver the highest quality clinical care by developing the latest cutting edge technologies in hybrid imaging, working in multidisciplinary partnership with colleagues in research and clinical practice, and supporting next generation of imaging doctors by promoting top quality education and training." - Dr. Irfan Kayani|
||"With the success of PET CT, the introduction of integrated PET MRI undoubtedly would be the multimodality imaging system of future; combining anatomical, functional, metabolic and multi-parametric imaging. At present, it is difficult to propose the potential numerous clinical benefits it imposes, because of lack of clinical evidence. However, PET MRI is already proving to be clinically useful because of the development and clinical introduction of new PET tracer that would offer increased diagnostic accuracy with increased in specificity and sensitivity in assessing loco-regional oncology especially in head-neck cancer, male and female pelvis, liver, musculo-skeletal tumours and neurological diseases. I foresee a great potential in therapy planning and response assessment in comparison to the present available imaging modalities." - Dr. Rizwan Syed|
"Ex umbris et imaginibus in veritatem (From shadows and images into the Truth)" - Dr. Leon Menezes
|Dr. Liz Prvulovich : Liz's special Interests include Governance, Nuclear Cardiology and Medical Education|
"During the last two decades we have firstly seen the increase of new
high resolution diagnostic imaging techniques, such as Computed
Tomography, with an increasing number of detectors and ultra thin
slices; or new sophisticated Magnetic Resonance machines with ultra
fast sequences and tissue characterization. We then moved to an era of
hybrid machines which combined the high advantages of new technologies
with functional information provided by Nuclear Medicine studies: PET
CT and more recently PET MR which are now entering deeply into
clinical routine allowing a simultaneous acquisition of different
The next challenge of the future will be the further development of these new all in one stop shop machines, enabling the provision of all morphological, tissue characterization and functional diagnostic information in combination with a large spectrum of non-invasive therapeutic procedures.
It is to be hoped that new modalities such as Focalized Ultrasound (HIFU), Chemotherapy microprobes, Selective Internal Radiation Therapy (SIRT), or Photodynamic therapy ( PDT) will be available in a solo machine, thus reducing diagnosis and treatment interval, recovery time and cost." - Dr. Francesco Fraioli
Medical Physics at the Institute of Nuclear Medicine
Medical Physics is the fundamental science underpinning all the imaging with in our department. Our Medical Physics group is central to supporting both our patient services and imaging research. The group ensures the safety of our patients and staff at all time.
The vision is to be at the forefront of medical physics development in nuclear medicine Imaging.
Our medical physics group is the largest UK Nuclear Medicine physics group in the UK. It contributes to national and international professional and scientific communities. The team includes clinical and academic physicists including postgraduates, undergraduates and clinical scientist trainees. We have expertise in radiation protection, imaging equipment design and assessment, performance evaluation, protocol development, image reconstruction and processing. The group also contributes scientific, technical and regulatory support of key importance to our own expanding research programme and to our collaborators.
INM has a large number of support staff, including radiographers, nuclear medicine technicians, nursing staff, research support staff, and admin team. All of the groups represented, are well trained, and highly professional, and cooperate as a cohesive team. We aim to support patients through their nuclear medicine experience by listening, empathising and through attention to detail in performing our duties.
INM is the first department in UK to be accredited by the European Association Of Nuclear Medicine. We hope that this is reflected in our practice, and that through constant evaluation we may continue to improve for the benefit of all our patients.
"Imaging has an important role in patient care. Developments in solid-state technology in Nuclear Medicine will enable whole body imaging with several tracers simultaneously, improving efficiency and diagnostic capabilities. Novel tracers, now mainly for PET but hopefully also for SPECT, will expand the diagnostic capabilities in Nuclear Medicine with impact on patient management.
Further progress in hybrid/multi-modality imaging will result in blurring of the borders between anatomical and functional imaging. Nuclear Medicine studies will be integrated into functional and anatomical imaging, regardless of the modality. This will enable more accurate and cost-efficient diagnosis and therapy as well as specific assessment suitable for each patient, i.e. personalized medicine.
Cost containment will drive personalized medicine, in which the various imaging modalities have a major role." - Professor Simona Ben-Haim
"Modern medical imaging is now able to capture a large amount of quantifiable biological information in a single examination. This multi-parametric approach is particularly applicable to the imaging of cancer where it can provide more accurate prognostic information and greater sophistication in the evaluation of response to treatment. Multi-parametric imaging therefore has the potential to improve outcomes for patients with cancer by contributing to ersonalised medicine in which imaging is an important factor in tailoring a patient’s treatment to their particular tumour."
- Professor Ken Miles
|"As biomedical advances continue to be made in the laboratory, the scope for radionuclide techniques to study physiology will expand, as for example the trafficking of stem cells. Physiological studies with radionuclides will also benefit from advances in hybrid imaging, as a result of improved anatomical co-registration of target processes, for example tissue glucose metabolism as traced by 18F-deoxyglucose and other tracer techniques based on newer novel positron-emitting tracers. Radionuclide techniques are well suited to these studies because they are non-invasive and, because the quantities of tracers administered are so small, they do not disturb, unlike say MRI agents, the processes being studied." - Professor Peters|
Page last modified on 30 aug 13 17:29